Zkusit zdarma
Centessa Pharmaceuticals plc

Centessa Pharmaceuticals plc

CNTA
Cena:
$ 39.75
-0.06 (-0.15%)
Valuace
70
Růst
30
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Are CNTA, WSR, GDOT Obtaining Fair Deals for their Shareholders?

Are CNTA, WSR, GDOT Obtaining Fair Deals for their Shareholders?

2:49 12-05-2026

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan...

Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA

Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA

12:43 11-05-2026

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, ...

38,432 Shares in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Acquired by B. Metzler seel. Sohn & Co. AG

38,432 Shares in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Acquired by B. Metzler seel. Sohn & Co. AG

3:44 27-04-2026

B. Metzler seel. Sohn and Co. AG purchased a new position in Centessa Pharmaceuticals PLC Sponsored ...

Shareholder Alert: The Ademi Firm investigates whether Centessa Pharmaceuticals plc is obtaining a Fair Price for Public Shareholders

Shareholder Alert: The Ademi Firm investigates whether Centessa Pharmaceuticals plc is obtaining a Fair Price for Public Shareholders

7:31 07-04-2026

MILWAUKEE, April 07, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Centessa (NASDAQ: CNTA) for...

Centessa Pharmaceuticals (NASDAQ:CNTA) Reaches New 1-Year High – What’s Next?

Centessa Pharmaceuticals (NASDAQ:CNTA) Reaches New 1-Year High – What’s Next?

5:52 02-04-2026

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ: CNTA - Get Free Report)'s stock price hit a new ...

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Centessa Pharmaceuticals plc (NASDAQ: CNTA)

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Centessa Pharmaceuticals plc (NASDAQ: CNTA)

16:14 01-04-2026

NEW YORK, April 1, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde  with Monteverde & ...

Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA

Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA

22:19 31-03-2026

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, ...

Why Centessa Stock Soared Today

Why Centessa Stock Soared Today

21:36 31-03-2026

Centessa possesses a promising sleep medicine pipeline. The clinical-stage company's experimental th...

Options Traders Pick Up Pharma Stock After Eli Lilly Buyout

Options Traders Pick Up Pharma Stock After Eli Lilly Buyout

15:40 31-03-2026

Centessa Pharmaceuticals PLC (NASDAQ:CNTA) shares are surging today, last seen 44.4% higher to tra...

Eli Lilly stock rises after $7.8B Centessa deal—bet on sleep drugs

Eli Lilly stock rises after $7.8B Centessa deal—bet on sleep drugs

12:24 31-03-2026

Eli Lilly has agreed to acquire Centessa Pharmaceuticals in a deal valued at up to $7.8 billion, mar...

Shareholder Alert: The Ademi Firm investigates whether Centessa Pharmaceuticals plc is obtaining a Fair Price for Public Shareholders

Shareholder Alert: The Ademi Firm investigates whether Centessa Pharmaceuticals plc is obtaining a Fair Price for Public Shareholders

12:00 31-03-2026

MILWAUKEE, March 31, 2026 /PRNewswire/ -- LLP is investigating Centessa (NASDAQ: CNTA) for possible ...

Dow Eyes Worst Month Since 2022 Despite Last Minute Flourish

Dow Eyes Worst Month Since 2022 Despite Last Minute Flourish

11:52 31-03-2026

Stocks are higher but all three major indexes are on track for monthly and quarterly losses...

Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs

Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs

10:46 31-03-2026

Eli Lilly will pay up to $7.8 billion to acquire Centessa Pharmaceuticals. Centessa is developing or...

Why Eli Lilly Is Buying Centessa for $7.8 Billion

Why Eli Lilly Is Buying Centessa for $7.8 Billion

10:27 31-03-2026

Bloomberg Intelligence's Sam Fazeli discusses Eli Lilly's $7.8 billion acquisition of Centessa, mark...

CNTA Stock Alert: Halper Sadeh LLC is Investigating Whether Centessa Pharmaceuticals plc is Obtaining a Fair Price for its Shareholders

CNTA Stock Alert: Halper Sadeh LLC is Investigating Whether Centessa Pharmaceuticals plc is Obtaining a Fair Price for its Shareholders

8:11 31-03-2026

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale ...

Eli Lilly to Buy Centessa Pharmaceuticals for Initial $6.3 Billion

Eli Lilly to Buy Centessa Pharmaceuticals for Initial $6.3 Billion

7:18 31-03-2026

Eli Lilly has agreed to buy clinical-stage company Centessa Pharmaceuticals for an initial $6.3 bill...

Eli Lilly to buy Centessa Pharma in $6.3 billion deal

Eli Lilly to buy Centessa Pharma in $6.3 billion deal

6:53 31-03-2026

Eli ​Lilly ‌said ​on ​Tuesday ⁠it ​would ​buy Centessa ​Pharmaceuticals ​in a ‌d...

Karen Anderson Sells 41,076 Shares of Centessa Pharmaceuticals (NASDAQ:CNTA) Stock

Karen Anderson Sells 41,076 Shares of Centessa Pharmaceuticals (NASDAQ:CNTA) Stock

4:38 28-03-2026

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ: CNTA - Get Free Report) insider Karen Anderson s...

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Recommendation of “Buy” from Brokerages

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Recommendation of “Buy” from Brokerages

2:22 23-03-2026

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ: CNTA - Get Free Report) has been assigned an ave...

Insider Selling: Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Sells $1,927,250.68 in Stock

Insider Selling: Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Sells $1,927,250.68 in Stock

4:21 16-03-2026

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ: CNTA - Get Free Report) insider Gregory Weinhoff...

close

NXERA PHARMA TO RECEIVE $1.8 MILLION MILESTONE PAYMENT FROM CENTESSA PHARMACEUTICALS

12-02-2026
TOKYO, JAPAN AND CAMBRIDGE, UK, 12 FEBRUARY 2026 – NXERA PHARMA CO., LTD. (“NXERA” OR “THE C...
Více zde

CENTESSA PHARMACEUTICALS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

03-02-2026
BOSTON AND LONDON, FEB. 03, 2026 (GLOBE NEWSWIRE) -- CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA), A...
Více zde

CENTESSA PHARMACEUTICALS ANNOUNCES POSTER PRESENTATION OF NEW PRECLINICAL DATA SUPPORTING EXPANSION OF OREXIN RECEPTOR 2 (OX2R) AGONIST PIPELINE INTO NEUROPSYCHIATRIC INDICATIONS AT THE 64TH ACNP ANNUAL MEETING

14-01-2026
ANTIDEPRESSIVE EFFECTS AND ENHANCED WAKEFULNESS WERE OBSERVED WITH OX2R ACTIVATION IN ESTABLISHED AN...
Více zde

NXERA PHARMA TO RECEIVE US$3.6 MILLION IN MILESTONE PAYMENT PURSUANT TO RESEARCH COLLABORATION WITH CENTESSA

13-01-2026
TOKYO, JAPAN AND CAMBRIDGE, UK, 13 JANUARY 2026 - NXERA PHARMA CO. , LTD. ("NXERA" OR "THE COMPANY";...
Více zde

CENTESSA PHARMACEUTICALS ANNOUNCES CEO TRANSITION AS COMPANY ADVANCES STRATEGY TO EXTEND OREXIN LEADERSHIP INTO MULTIPLE NEUROSCIENCE INDICATIONS

11-12-2025
MARIO ALBERTO ACCARDI PHD, PRESIDENT AND FOUNDER OF CENTESSA'S OREXIN PROGRAM, APPOINTED CHIEF EXECU...
Více zde

CENTESSA PHARMACEUTICALS ANNOUNCES PRICING OF $250,000,000 PUBLIC OFFERING OF AMERICAN DEPOSITARY SHARES

11-11-2025
BOSTON AND LONDON, NOV. 11, 2025 (GLOBE NEWSWIRE) -- CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA), A ...
Více zde

CENTESSA PHARMACEUTICALS ANNOUNCES PROPOSED PUBLIC OFFERING OF AMERICAN DEPOSITARY SHARES

11-11-2025
BOSTON AND LONDON, NOV. 11, 2025 (GLOBE NEWSWIRE) -- CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA), A ...
Více zde

CENTESSA PHARMACEUTICALS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

07-11-2025
BOSTON AND LONDON, NOV. 07, 2025 (GLOBE NEWSWIRE) -- CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA), A...
Více zde

CENTESSA PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2025 AND PROVIDES UPDATE ON POTENTIAL BEST-IN-CLASS OREXIN RECEPTOR 2 (OX2R) AGONIST PROGRAM

05-11-2025
BOSTON AND LONDON, NOV. 05, 2025 (GLOBE NEWSWIRE) -- CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA), A ...
Více zde

CENTESSA PHARMACEUTICALS TO PARTICIPATE IN THE MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE

03-09-2025
BOSTON AND LONDON, SEPT. 03, 2025 (GLOBE NEWSWIRE) -- CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA), ...
Více zde

CENTESSA PHARMACEUTICALS REPORTS FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS FOR THE SECOND QUARTER OF 2025

12-08-2025
ADVANCING A BROAD, POTENTIAL BEST-IN-CLASS OREXIN RECEPTOR 2 (OX2R) AGONIST FRANCHISE, WITH KEY DATA...
Více zde

NXERA PHARMA TO RECEIVE US$4.8 MILLION IN MILESTONE PAYMENTS FOLLOWING CENTESSA'S INITIATION OF CLINICAL DEVELOPMENT OF ORX142, A NOVEL OREXIN RECEPTOR 2 (OX2R) AGONIST

04-07-2025
TOKYO, JAPAN AND CAMBRIDGE, UK, 4 JULY 2025 – NXERA PHARMA CO., LTD. (“NXERA” OR “THE COMPAN...
Více zde

CENTESSA PHARMACEUTICALS ANNOUNCES CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION (IND) FOR ORX142, A NOVEL OREXIN RECEPTOR 2 (OX2R) AGONIST; CLINICAL DATA IN ACUTELY SLEEP-DEPRIVED HEALTHY VOLUNTEERS PLANNED FOR THIS YEAR

16-06-2025
BOSTON AND LONDON, JUNE 16, 2025 (GLOBE NEWSWIRE) -- CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA), A ...
Více zde

CENTESSA PHARMACEUTICALS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

19-05-2025
BOSTON AND LONDON, MAY 19, 2025 (GLOBE NEWSWIRE) -- CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA), A ...
Více zde

CENTESSA PHARMACEUTICALS REPORTS FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS FOR THE FIRST QUARTER OF 2025

14-05-2025
BOSTON AND LONDON, MAY 14, 2025 (GLOBE NEWSWIRE) -- CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA), A C...
Více zde

CENTESSA PHARMACEUTICALS REPORTS BUSINESS HIGHLIGHTS AND FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL-YEAR 2024

24-03-2025
BOSTON AND LONDON, MARCH 24, 2025 (GLOBE NEWSWIRE) -- CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA), A...
Více zde

CENTESSA PHARMACEUTICALS ANNOUNCES POSTER PRESENTATION OF PHASE 1 CLINICAL DATA FOR ORX750, A NOVEL OREXIN RECEPTOR 2 (OX2R) AGONIST, AT THE AMERICAN ACADEMY OF NEUROLOGY (AAN) 2025 ANNUAL MEETING

06-03-2025
BOSTON AND LONDON, MARCH 06, 2025 (GLOBE NEWSWIRE) -- CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA), A...
Více zde

CENTESSA PHARMACEUTICALS ANNOUNCES APPOINTMENT OF STEPHEN KANES, MD PHD, AS CHIEF MEDICAL OFFICER

08-01-2025
BOSTON AND LONDON, JAN. 08, 2025 (GLOBE NEWSWIRE) -- CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA), A ...
Více zde

CENTESSA PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2024 AND PROVIDES BUSINESS UPDATE

12-11-2024
BOSTON AND LONDON, NOV. 12, 2024 (GLOBE NEWSWIRE) -- CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA), A...
Více zde

CENTESSA PHARMACEUTICALS PRESENTS PRECLINICAL DATA FOR ORX142, A NOVEL OREXIN RECEPTOR 2 (OX2R) AGONIST, AT THE 27TH CONGRESS OF THE EUROPEAN SLEEP RESEARCH SOCIETY (SLEEP EUROPE 2024)

26-09-2024
LATE-BREAKING POSTER PRESENTATION OF NON-HUMAN PRIMATE (NHP) DATA SUPPORT ORX142 AS NOVEL DRUG CANDI...
Více zde

CENTESSA PHARMACEUTICALS ANNOUNCES PRICING OF UPSIZED $225,000,000 PUBLIC OFFERING OF AMERICAN DEPOSITARY SHARES

12-09-2024
BOSTON AND LONDON, SEPT. 12, 2024 (GLOBE NEWSWIRE) -- CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA), A...
Více zde

CENTESSA PHARMACEUTICALS ANNOUNCES $150,000,000 PROPOSED PUBLIC OFFERING OF AMERICAN DEPOSITARY SHARES

11-09-2024
BOSTON AND LONDON, SEPT. 11, 2024 (GLOBE NEWSWIRE) -- CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA), A...
Více zde

CENTESSA ANNOUNCES POSITIVE INTERIM PHASE 1 CLINICAL DATA WITH ITS NOVEL OREXIN RECEPTOR 2 (OX2R) AGONIST, ORX750, IN ACUTELY SLEEP-DEPRIVED HEALTHY VOLUNTEERS

10-09-2024
BOSTON AND LONDON, SEPT. 10, 2024 (GLOBE NEWSWIRE) -- CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA), A...
Více zde

CENTESSA PHARMACEUTICALS ANNOUNCES LATE-BREAKING POSTER PRESENTATION OF NON-HUMAN PRIMATE DATA FOR ORX142, A NOVEL OREXIN RECEPTOR 2 (OX2R) AGONIST, AT THE 27TH CONGRESS OF THE EUROPEAN SLEEP RESEARCH SOCIETY (SLEEP EUROPE 2024)

27-08-2024
ORX142 IS CURRENTLY IN IND ENABLING ACTIVITIES FOR SELECT NEUROLOGICAL, NEURODEGENERATIVE, AND PSYCH...
Více zde

CENTESSA PHARMACEUTICALS TO PARTICIPATE IN THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE

21-08-2024
BOSTON AND LONDON, AUG. 21, 2024 (GLOBE NEWSWIRE) -- CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA), A ...
Více zde

CENTESSA PHARMACEUTICALS REPORTS FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS FOR THE SECOND QUARTER OF 2024

13-08-2024
BOSTON AND LONDON, AUG. 13, 2024 (GLOBE NEWSWIRE) -- CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA), A ...
Více zde

CENTESSA PHARMACEUTICALS STRENGTHENS EXECUTIVE LEADERSHIP WITH APPOINTMENT OF JOHN CROWLEY CPA, AS CHIEF FINANCIAL OFFICER AND GREGORY WEINHOFF MD MBA, AS CHIEF BUSINESS OFFICER

10-06-2024
BOSTON AND LONDON, JUNE 10, 2024 (GLOBE NEWSWIRE) -- CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA), A...
Více zde

CENTESSA PHARMACEUTICALS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

21-05-2024
BOSTON AND LONDON, MAY 21, 2024 (GLOBE NEWSWIRE) -- CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA), A C...
Více zde

CENTESSA PHARMACEUTICALS REPORTS FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS FOR THE FIRST QUARTER OF 2024

13-05-2024
BOSTON AND LONDON, MAY 13, 2024 (GLOBE NEWSWIRE) -- CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA), A C...
Více zde

CENTESSA PHARMACEUTICALS ANNOUNCES PRICING OF $100 MILLION PUBLIC OFFERING OF AMERICAN DEPOSITARY SHARES

23-04-2024
BOSTON AND LONDON, APRIL 23, 2024 (GLOBE NEWSWIRE) -- CENTESSA PHARMACEUTICALS PLC  (NASDAQ: CNTA...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-02-13 00:00:008-KStáhnout
2025-12-11 00:00:008-KStáhnout
2025-11-24 00:00:008-KStáhnout
2025-11-13 00:00:008-KStáhnout
2025-11-05 00:00:008-KStáhnout
2025-11-05 00:00:0010-QStáhnout
2025-08-12 01:00:008-KStáhnout
2025-08-12 01:00:0010-QStáhnout
2025-08-12 00:00:008-KStáhnout
2025-08-12 00:00:0010-QStáhnout
2025-06-20 01:00:008-KStáhnout
2025-06-20 00:00:008-KStáhnout
2025-06-17 01:00:008-KStáhnout
2025-06-17 00:00:008-KStáhnout
2025-05-29 01:00:008-KStáhnout
2025-05-29 00:00:008-KStáhnout
2025-05-14 01:00:008-KStáhnout
2025-05-14 01:00:0010-QStáhnout
2025-05-14 00:00:008-KStáhnout
2025-05-14 00:00:0010-QStáhnout
2025-03-24 00:00:008-KStáhnout
2025-03-24 00:00:0010-KStáhnout
2025-03-23 23:00:008-KStáhnout
2025-03-23 23:00:0010-KStáhnout
2025-02-21 00:00:008-KStáhnout
2025-02-20 23:00:008-KStáhnout
2025-01-08 00:00:008-KStáhnout
2025-01-07 23:00:008-KStáhnout
2024-12-30 00:00:008-KStáhnout
2024-12-29 23:00:008-KStáhnout
2024-11-12 00:00:008-KStáhnout
2024-11-12 00:00:0010-QStáhnout
2024-11-11 23:00:008-KStáhnout
2024-11-11 23:00:0010-QStáhnout
2024-09-13 01:00:008-KStáhnout
2024-09-13 00:00:008-KStáhnout
2024-09-10 01:00:008-KStáhnout
2024-09-10 00:00:008-KStáhnout
2024-08-13 01:00:008-KStáhnout
2024-08-13 01:00:0010-QStáhnout
2024-08-13 00:00:008-KStáhnout
2024-08-13 00:00:0010-QStáhnout
2024-06-25 01:00:008-KStáhnout
2024-06-25 00:00:008-KStáhnout
2024-06-10 01:00:008-KStáhnout
2024-06-10 00:00:008-KStáhnout
2024-05-13 01:00:008-KStáhnout
2024-05-13 01:00:0010-QStáhnout
2024-05-13 00:00:008-KStáhnout
2024-05-13 00:00:0010-QStáhnout
2024-04-24 01:00:008-KStáhnout
2024-04-24 00:00:008-KStáhnout
2024-04-22 01:00:008-KStáhnout
2024-04-22 00:00:008-KStáhnout
2024-03-28 00:00:008-KStáhnout
2024-03-28 00:00:0010-KStáhnout
2024-03-27 23:00:008-KStáhnout
2024-03-27 23:00:0010-KStáhnout
2024-02-09 00:00:008-KStáhnout
2024-02-08 23:00:008-KStáhnout
2024-01-09 00:00:008-KStáhnout
2024-01-08 23:00:008-KStáhnout
2023-12-11 00:00:008-KStáhnout
2023-12-10 23:00:008-KStáhnout
2023-11-13 00:00:008-KStáhnout
2023-11-13 00:00:0010-QStáhnout
2023-11-12 23:00:008-KStáhnout
2023-11-12 23:00:0010-QStáhnout
2023-10-25 01:00:008-KStáhnout
2023-10-25 00:00:008-KStáhnout
2023-08-24 01:00:008-KStáhnout
2023-08-24 00:00:008-KStáhnout
2023-08-14 01:00:008-KStáhnout
2023-08-14 01:00:0010-QStáhnout
2023-08-14 00:00:008-KStáhnout
2023-08-14 00:00:0010-QStáhnout
2023-07-10 01:00:008-KStáhnout
2023-07-10 00:00:008-KStáhnout
2023-06-22 01:00:008-KStáhnout
2023-06-22 00:00:008-KStáhnout
2023-06-09 01:00:008-KStáhnout
2023-06-09 00:00:008-KStáhnout
2023-05-22 01:00:008-KStáhnout
2023-05-22 00:00:008-KStáhnout
2023-05-12 01:00:008-KStáhnout
2023-05-12 01:00:0010-QStáhnout
2023-05-12 00:00:008-KStáhnout
2023-05-12 00:00:0010-QStáhnout
2023-03-30 01:00:008-KStáhnout
2023-03-30 01:00:0010-KStáhnout
2023-03-30 00:00:008-KStáhnout
2023-03-30 00:00:0010-KStáhnout
2023-01-27 00:00:008-KStáhnout
2023-01-26 23:00:008-KStáhnout
2023-01-26 00:00:008-KStáhnout
2023-01-25 23:00:008-KStáhnout
2022-12-23 00:00:008-KStáhnout
2022-12-22 23:00:008-KStáhnout
2022-12-12 00:00:008-KStáhnout
2022-12-11 23:00:008-KStáhnout
2022-11-10 00:00:008-KStáhnout
2022-11-10 00:00:0010-QStáhnout
2022-11-09 23:00:008-KStáhnout
2022-11-09 23:00:0010-QStáhnout
2022-10-14 01:00:008-KStáhnout
2022-10-14 00:00:008-KStáhnout
2022-10-06 01:00:008-KStáhnout
2022-10-06 00:00:008-KStáhnout
2022-08-10 01:00:008-KStáhnout
2022-08-10 01:00:0010-QStáhnout
2022-08-10 00:00:008-KStáhnout
2022-08-10 00:00:0010-QStáhnout
2022-07-08 01:00:008-KStáhnout
2022-07-08 00:00:008-KStáhnout
2022-07-01 01:00:008-KStáhnout
2022-07-01 00:00:008-KStáhnout
2022-06-30 01:00:008-KStáhnout
2022-06-30 00:00:008-KStáhnout
2022-06-02 01:00:008-KStáhnout
2022-06-02 00:00:008-KStáhnout
2022-05-16 01:00:008-KStáhnout
2022-05-16 01:00:0010-QStáhnout
2022-05-16 00:00:008-KStáhnout
2022-05-16 00:00:0010-QStáhnout
2022-03-30 01:00:008-KStáhnout
2022-03-30 01:00:0010-KStáhnout
2022-03-30 00:00:008-KStáhnout
2022-03-30 00:00:0010-KStáhnout
2022-02-24 00:00:008-KStáhnout
2022-02-23 23:00:008-KStáhnout
2022-02-16 00:00:008-KStáhnout
2022-02-15 23:00:008-KStáhnout
2022-02-14 00:00:008-KStáhnout
2022-02-13 23:00:008-KStáhnout
2021-12-14 00:00:008-KStáhnout
2021-12-13 23:00:008-KStáhnout
2021-11-15 00:00:008-KStáhnout
2021-11-15 00:00:0010-QStáhnout
2021-11-14 23:00:008-KStáhnout
2021-11-14 23:00:0010-QStáhnout
2021-11-01 00:00:008-KStáhnout
2021-10-31 23:00:008-KStáhnout
2021-10-04 01:00:008-KStáhnout
2021-10-04 00:00:008-KStáhnout
2021-09-09 01:00:008-KStáhnout
2021-09-09 00:00:008-KStáhnout
2021-08-16 01:00:008-KStáhnout
2021-08-16 01:00:0010-QStáhnout
2021-08-16 00:00:008-KStáhnout
2021-08-16 00:00:0010-QStáhnout
preloader